Research Article
Symptomatic Correlates of Vitamin D Deficiency in First-Episode Psychosis
Table 1
Demographic and clinical characteristics of the study samples.
| | FEP (n=33) | MEP (n=33) | P |
| Age (years), mean (SD) | 31.21 (10.03) | 41.15 (9.88) | <0.001† | Gender, n (%) | | | | Male | 23 (69.70%) | 23 (69.70%) | 1.000‡ | Female | 10 (69.30%) | 10 (69.30%) | | Ethnicity, n (%) | | | | White | 32 (96.97%) | 32 (96.97%) | 1.000‡ | Black | 1 (3.03%) | 1 (3.03%) | | Education (years), mean (SD) | 10.28 (3.40) | | | Marital status, n (%) | | | | Single/divorced | 7 (21.21%) | 7 (21.21%) | 1.000‡ | Married/partner | 26 (78.78%) | 26 (78.78%) | | Blood collection season, n (%) | | | | Summer season | 16 (48.48%) | 11 (33.33%) | 0.211‡ | Winter season | 17 (51.51%) | 22 (66.66%) | | Tobacco, n (%) | | | | Yes | 14 (42.42%) | 19 (57.57%) | 0.218‡ | No | 19 (57.57%) | 14 (42.42%) | | Weight (kg), mean (SD) | 70.86 (14.37) | 74.86 (14.11) | 0.257† | BMI (kg/m2), mean (SD) | 23.85 (4.12) | 25.08 (3.92) | 0.221† | Diagnosis, n (%) | | | | Schizophrenia | 12 (36.36%) | 19 (57.58%) | 0.148§ | Delusional disorder | 5 (15.15%) | 2 (6.06%) | | Psychosis NOS | 7 (21.21%) | 1 (3.03%) | | Bipolar disorder | 2 (6.06%) | 4 (12.12%) | Psychotic depression | 4 (12.12%) | 2 (6.06%) | | Cannabis induced psychosis | 2 (6.06%) | 3 (9.09%) | | Schizo-affective disorder | 1 (3.03%) | 2 (6.06%) | | Cannabis use, n (%) | | | | Yes | 6 (18.18%) | | | Duration of untreated psychosis (DUP) (days), mean (SD) | 450.54 (952.64) | | | Global Assessment Functioning (GAF), mean (SD) | 59.21 (9.44) | | | Medication Adherence Rating Scale (MARS), Mean (SD) | 6.40 (2.14) | | | Depressive symptom score (BDI), Mean (SD) | 12.42 (9.10) | | | Positive symptom subscale score (PANSS), Mean (SD) | 12.84 (3.57) | | | Negative symptom subscale score (PANSS), Mean (SD) | 16.09 (7.27) | | | General psychopathology subscale score (PANSS), Mean (SD) | 31.59 (7.43) | | |
|
|
’s t-test ‡Chi-squared test §Fisher’s exact test |